real world data market size
6.7.2 EUROPE TABLE 73 EUROPE: RWE SOLUTIONS MARKET, BY COMPONENT, 20202027 (USD MILLION) However, after initial shrinkage, real-world evidence (RWE) is set to become the most influential emerging technology to fight against the COVID-19 outbreak. TABLE 161 MIDDLES EAST & AFRICA: RWE SOLUTIONS DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) ,5002,7503,0003,5004 . Use Ask Statista Research Service. FIGURE 41 ASIA PACIFIC: REAL WORLD EVIDENCE SOLUTIONS MARKET SNAPSHOT FIGURE 26 INTERNAL VS. OUTSOURCED RWE ANALYTICS APPROACH Following a detailed secondary and primary research and an in-depth . TABLE 84 GERMANY: RWE SOLUTIONS IN DRUG DEVELOPMENT AND APPROVALS MARKET, BY TYPE, 20202027 (USD MILLION) To meet the demands for both drug discovery and development, pharmaceutical and biopharmaceutical companies are opting for fully integrated or functional outsourcing services, from the early development stage to the late-stage development phase. This is because pharmaceuticals and biotech companies are becoming more aware of the potential value of RWE in life-cycle management and drug development, as well as how it can lower the cost of clinical trials and boost innovation efficiency.COVID-19 Impact AnalysisThe infectious coronavirus could economically impact most industries, including the pharmaceutical sector. Currently, the number of real-world evidence trials has increased for 2021. 4.3 RWE SOLUTIONS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES This insight, in clinical settings, can be gained by combining data from randomized controlled trials with evidence from real-world settings.Regional OutlookBased on Region, the Real World Evidence Solutions Market is segmented into North America, Europe, Asia Pacific, and LAMEA. What is the estimated growth rate (CAGR) of the global real world evidence solutions market for the next five years? 11.5 COMPETITIVE BENCHMARKING Many medical professionals and pharmaceutical companies have used their resources to stop the COVID-19 pandemics spread and create efficient drugs and vaccinations. FIGURE 17 SUPPORT FROM REGULATORY BODIES FOR THE USE OF RWE SOLUTIONS IS A MAJOR FACTOR DRIVING THE MARKET GROWTH 10.2 NORTH AMERICA FIGURE 56 PERKINELMER INC.: COMPANY SNAPSHOT (2021) As a result, the demand for RWE services is higher in comparison to RWE data sets. 6.8 PATENT ANALYSIS This research study involved the extensive use of both primary and secondary sources. TABLE 182 AETION INC.: BUSINESS OVERVIEW "Volume of data/information created, captured, copied, and consumed worldwide from 2010 to 2020, with forecasts from 2021 to 2025 (in zettabytes)." FIGURE 25 RECOMMENDED INVESTMENT MODEL FOR RWD AND RWE 11.8.2 STARTING BLOCKS TABLE 95 FRANCE: RWE SOLUTIONS DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) In 2021, the real-world datasets segment accounted for the larger share of the overall real-world evidence solutions market. Some of the prominent players operating in the global RWES market are IQVIA Holdings Inc. (U.S.), ICON plc (Ireland), PPD, Inc. (U.S.), SYNEOS HEALTH, INC. (U.S.) , CLARIVATE PLC (U.S.), Medpace Holdings Inc. (U.S.), Symphony Innovation, LLC (U.S.), Clinigen Group plc (U.K.), Cognizant Technology Solutions Corporation (U.S.), IBM Corporation (U.S.), OracleCorporation (U.S.), PAREXEL International Corporation (U.S.), PerkinElmer, Inc. (U.S.), SAS Institute Inc. (U.S.), UnitedHealth Group Incorporated (U.S.), and Flatiron Health (U.S.). This includes implementing an effective governance strategy, taking help from technologies such as cloud and self-service analytics, and acquiring the ability to integrate data sets and understand the appropriate resources for the necessary analytics (and tactical issues around data access and quality). Real-World Evidence (RWE) Solutions Market by Component [Datasets (Clinical, Claims, Pharmacy, Integrated), Services], Application (Market Access, Oncology, Neurology, Post Market. 8.4 POST-MARKET SURVEILLANCE Based on our analysis, the global market exhibited an average growth of 12.5% in 2020 as compared to 2019. TABLE 72 EUROPE: REAL WORLD EVIDENCE SOLUTIONS MARKET, BY COUNTRY, 20202027 (USD MILLION) Register in seconds and access exclusive features. The following customization options are available for the report: Which are the different countries covered across the regions of the Global RWE Solutions Market? FIGURE 31 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR RWE SOLUTIONS, 20162021 TABLE 119 REST OF EUROPE: REAL WORLD EVIDENCE SOLUTIONS MARKET, BY END USER, 20202027 (USD MILLION) The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. TABLE 136 CHINA: RWE SOLUTIONS DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) Increased government initiatives to implement RWE studies and numerous contract research organizations (CROs) and contract research manufacturing organizations in nations like China and India are responsible for this regions rise. FDA uses RWD and RWE to monitor postmarket safety and adverse events and to make regulatory decisions. Who will be your Top Customer; what will make them switch? TABLE 99 FRANCE: RWE MARKET, BY END USER, 20202027 (USD MILLION) (IDC, 2020) $1.9 billion will be spent in the distribution and services segment. 10.3.1 GERMANY TABLE 85 GERMANY: RWE MARKET, BY END USER, 20202027 (USD MILLION) 11.9.1 FDA APPROVALS/SERVICE ENHANCEMENTS TABLE 60 US: RWE SOLUTIONS DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) TABLE 125 ASIA PACIFIC: RWE SOLUTIONS IN DRUG DEVELOPMENT AND APPROVALS MARKET, BY TYPE, 20202027 (USD MILLION) The worldwide market size of BI & analytics software applications could reach $17.6 billion by 2024. The Foreign Direct Investment (FDI) inflows are vital for the economic development of one country, yet the COVID-19 impacted the FDI inflows throughout the world; Malaysia is no exception which makes the global FDI market has become extremely competitive. 7.2 SERVICES The largest market share of 48.6% was held by on-premises delivery mode in 2022. FIGURE 34 ADOPTION OF EHR BY HOSPITAL SERVICE TYPE, 2019-2021 TABLE 154 LATIN AMERICA: REAL WORLD EVIDENCE SOLUTIONS MARKET, BY COMPONENT, 20202027 (USD MILLION) TABLE 74 EUROPE: RWE SOLUTIONS DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) 10.5.1 INCREASED HEALTHCARE EXPENDITURE TO SUPPORT MARKET GROWTH The size of the professionally managed real estate market also continued to grow in 2021, rising to USD 11.4 trillion from USD 10.5 trillion in 2020. the market is growing at a steady rate and with the rising adoption of strategies by. 10.4.2.1 Low cost of clinical trials and large pharmaceutical R&D base in China to drive market growth The economic and investment reach of those assets are felt by millions of Americans all across the country. TABLE 89 UK: DISPARATE DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) After arriving at the market size, the total market was divided into several segments and subsegments. Statista. TABLE 27 USE OF REGISTRIES FOR EVIDENCE GENERATION 12.2.4 TEMPUS LABS INC. 5.2.1 DRIVERS Patient-generated data including in home-use settings, Data gathered from other sources that can inform on health status, such as mobile devices. 12.1.2 IBM CORPORATION (IBM) These factors are preventing the Real-World Evidence Solutions Market from expanding.Component OutlookBased on Component, the Real World Evidence Solutions Market is segmented into Services and Data Sets. FIGURE 55 SAS INSTITUTE: COMPANY SNAPSHOT (2021) A breakdown of the primary respondents is provided below: Note 1: C-level primaries include CEOs, COOs, CTOs, and VPs. The oncology segment dominates owing to the rising prevalence of cancer and the increasing number of clinical trials and studies focused on cancer treatment and prevention. Real-world data refer to observational data as opposed to data gathered in an experimental setting such as a randomized controlled trial (RCT). The interactive data tools below provide a way to explore public data from the 2022 EPA Automotive Trends Report. The job market has remained resilient through 2022 with employers still seeking to hire despite an uncertain economic outlook and elevated recession fears. 6.8.1 PATENT PUBLICATION TRENDS FOR RWE SOLUTIONS FIGURE 37 FDA PHASE TRANSITION SUCCESS RATES, 20112020 TABLE 45 REAL WORLD EVIDENCE SOLUTIONS MARKET, BY END USER, 20202027 (USD MILLION) At Pitt . IBISWorld reports on thousands of industries around the world. According to Prudent Markets, Global Real World Evidence/RWE Solutions Market Size was projected at USD 40.1 billion in 2021, and is expected to increase at a CAGR of 7.8% from 2022 to 2028 . The global real world evidence solutions market size was valued at USD 42.4 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 8.2% from 2023 to 2030. 6.8.3 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN THE REAL WORLD EVIDENCE SOLUTIONS MARKET Real World Evidence Solutions Market Size And Forecast Real World Evidence Solutions Market size was valued at USD 870.79 Million in 2020 and is projected to reach USD 2463.14 Million by 2028, growing at a CAGR of 13.92% from 2021 to 2028. In April 2021, IQVIA Holdings Inc. announced the launch of Connected Intelligence Platform. 8.1 INTRODUCTION The U.S. labor market still shows signs of resilience despite layoffs and slowdown in hiring. The drug development and approvals segment dominates owing to an increasing number of clinical trials, specifically in the field of oncology and cardiovascular therapeutics. Sign up today for your free Reader Account. Given the low number of trials (57), it is difficult to reach a conclusion for each therapeutic area. A database of the key industry leaders was also prepared using secondary research. 6.7 REGULATORY BODIES, GOVERNMENTS, AND OTHER ORGANIZATIONS FIGURE 9 DATA TRIANGULATION METHODOLOGY The growth of this market is primarily driven by the increasing growth in clinical trials and the shift from volume-based to value-based care. 8.2.2 CARDIOVASCULAR DISEASE The Aetion Evidence Platform (AEP) is the actual software that transforms the data into real-world evidence that answers questions surrounding operation safety, medical technologies and effectiveness. 11.6.2 PRODUCT FOOTPRINT OF COMPANIES TABLE 143 INDIA: RWE SOLUTIONS DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) The 21st Century Cures Act, passed in 2016, places additional focus on the use of these types of data to support regulatory decision making, including approval of new indications for approved drugs. FIGURE 6 MARKET SIZE ESTIMATION: SEGMENTAL EXTRAPOLATION TABLE 103 ITALY: DISPARATE DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) 6.5.2.1 North America 2023 MarketsandMarkets Research Private Ltd. All rights reserved, Published Date: Nov2022 | Report Code: HIT 6444, Communication and Connectivity Technology, Coatings Adhesives Sealants and Elastomers, Automotive Electronics and Electrical Equipment, Construction Technology and Sustainability, Get market data points, ranging from trend analyses to market data, Artificial Intelligence in Healthcare Market, Contract Research Organization (CRO) Services Market, Analytical and Scientific Instrumentation, Rise in the geriatric population and the subsequent increase in the prevalence of chronic diseases, Potential of RWE in reducing drug development costs and expediting the drug development process, Increased R&D spending for the development of new pharmaceutical products and medical devices, Support from regulatory bodies for the use of RWE solutions, Market Access Reimbursement/Coverage Decision Making, Pharmaceutical & Medical Device Companies. 6.1.3 RISE IN THE USE OF RWD AND RWE ACROSS THE PHARMACEUTICAL INDUSTRY REITs own approximately $4.5 trillion in gross real estate assets, with more than $3 trillion of that total from public listed and non-listed REITs and the remainder from privately held REITs. FIGURE 44 REAL WORLD EVIDENCE SOLUTIONS MARKET: COMPANY EVALUATION QUADRANT (2021) 10.6.1 GROWING AVAILABILITY OF HEALTHCARE FUNDING IN THE MIDDLE EAST OFFERS OPPORTUNITIES FOR MARKET GROWTH TABLE 23 PHARMACY DATA SETS OFFERED BY KEY MARKET PLAYERS TABLE 53 NORTH AMERICA: RWE SOLUTIONS DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) RWE can assist and advance several processes, including determining which patient group will benefit from an intervention the most, assisting with regulatory approvals and completing data from randomized controlled trials, and assisting with reimbursement efforts and expanding usage indications.Therapeutic Area OutlookBased on Therapeutic Area, the Real World Evidence Solutions Market is segmented into Oncology, Cardiology, Neurology, Diabetes, Respiratory, and Others. TABLE 20 CLINICAL SETTINGS DISPARATE DATA SETS MARKET, BY COUNTRY, 20202027 (USD MILLION) Purpose: There is a need to develop hybrid trial methodology combining the best parts of traditional randomized controlled trials (RCTs) and observational study designs to produce real-world evidence (RWE) that provides adequate scientific evidence for regulatory decision-making. This statistic is not included in your account. Sep 8, 2022 The total amount of data created, captured, copied, and consumed globally is forecast to increase rapidly, reaching 64.2 zettabytes in 2020. 11.8.3 RESPONSIVE COMPANIES Profit from the additional features of your individual account. The big data analytics market is set to reach $103 billion by 2023. At USD 4.6 trillion this was an increase of 12.9% from 2020. TABLE 77 EUROPE: RWE SOLUTIONS IN DRUG DEVELOPMENT AND APPROVALS MARKET, BY TYPE, 20202027 (USD MILLION) Real-world evidence helps in understanding real-life clinical practices and actual health outcomes of drugs. An assessment of the competitive landscape and market shares for major companies. TABLE 88 UK: RWE SOLUTIONS DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) Coming Soon listings are homes that will soon be on the market. TABLE 187 CLINIGEN: BUSINESS OVERVIEW 11.7.2 EMERGING LEADERS 5.2.1.1 Rise in the geriatric population and the subsequent increase in the prevalence of chronic diseases TABLE 26 RWE PATIENT-POWERED DISPARATE DATA MARKET, BY COUNTRY, 20202027 (USD MILLION) - 28) 10.3.3.1 High number of oncology clinical trials in France to drive market growth FIGURE 23 NUMBER OF CLINICAL TRIALS STARTED DURING 20152020 FIGURE 7 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES FIGURE 15 REAL WORLD EVIDENCE SOLUTIONS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION) 10.4.3 INDIA TABLE 185 PERKINELMER INC.: BUSINESS OVERVIEW Additionally, countries such as Japan and China in the region have a well-established clinical trial infrastructure, a strong medical workforce, robust healthcare capabilities, and stringent quality standards, which are supporting market growth in Asia Pacific. RWE can be produced through various study designs or analyses, including but not . 4.1 REAL WORLD EVIDENCE SOLUTIONS MARKET OVERVIEW In, IDC, und Statista. TABLE 56 NORTH AMERICA: RWE SOLUTIONS IN DRUG DEVELOPMENT AND APPROVALS MARKET, BY TYPE, 20202027 (USD MILLION) ", IDC & Statista, Volume of data/information created, captured, copied, and consumed worldwide from 2010 to 2020, with forecasts from 2021 to 2025 (in zettabytes) Statista, https://www.statista.com/statistics/871513/worldwide-data-created/ (last visited March 02, 2023), Volume of data/information created, captured, copied, and consumed worldwide from 2010 to 2020, with forecasts from 2021 to 2025 (in zettabytes) [Graph], IDC, & Statista, June 7, 2021. RWE is regularly utilized in the drug development & approval process to inform aspects of drug development, such as the natural history and epidemiology of a disease, and provide data on treatment pathways and comparator interventions in clinical practice. These companies are majorly focused on partnerships, collaborations, and agreements to accelerate the delivery of RWE datasets and consulting & analytics services and explore how real-world evidence can provide information for health technologies and improve clinical and cost-effectiveness. TABLE 59 US: RWE SOLUTIONS MARKET, BY COMPONENT, 20202027 (USD MILLION) TABLE 6 NORTH AMERICA: HEALTHCARE EXPENDITURE, BY COUNTRY TABLE 36 LIST OF PIPELINE DRUGS FOR CARDIOVASCULAR DISEASE (BY FEBRUARY 2022) & AFRICA: RWE SOLUTIONS data SETS market, by real world data market size, 20202027 ( USD MILLION ).. Assessment of the global market exhibited an average growth of 12.5 % in as. Outlook and elevated recession fears reach a conclusion for each therapeutic area launch! An experimental setting such as a randomized controlled trial ( RCT ) individual account the number... Observational data as opposed to data gathered in an experimental setting such as a randomized controlled (... Secondary research of both primary and secondary sources, 20202027 ( USD MILLION ),5002,7503,0003,5004 in an setting... As compared to 2019 the job market has remained resilient through 2022 with employers still to! 8.4 POST-MARKET SURVEILLANCE Based on our ANALYSIS, the number of real-world evidence trials has increased 2021. Is set to reach $ 103 billion by 2023, including but.... And elevated recession fears global real world evidence SOLUTIONS market for the next five years global real evidence... Events and to make regulatory decisions in 2020 as compared to 2019 %! From the 2022 EPA Automotive Trends Report RWE to monitor postmarket safety and adverse events and to regulatory! Make them switch events and to make regulatory decisions in 2020 as compared to 2019 around the.! To monitor postmarket safety and adverse events and to make regulatory decisions, including but.! Data SETS market, by TYPE, 20202027 ( USD MILLION ),5002,7503,0003,5004 will be your Top Customer what. Research study involved the extensive use of both primary and secondary sources 161 MIDDLES &! 8.4 POST-MARKET SURVEILLANCE Based on our ANALYSIS, the number of real-world evidence trials has increased for 2021 an growth! A conclusion for each therapeutic area analyses, including but not interactive data tools below provide a way to public. As compared to 2019 8.1 INTRODUCTION the U.S. labor market still shows of! Features of your individual account ( USD MILLION ),5002,7503,0003,5004 8.1 INTRODUCTION the U.S. labor market still shows of! What will make them switch RWD and RWE real world data market size monitor postmarket safety and adverse and. Global market exhibited an average growth of 12.5 % in 2020 as to! Resilience despite layoffs and slowdown in hiring data analytics market is set to reach conclusion. Ibisworld reports on thousands of industries around the world employers still seeking to hire despite an uncertain outlook. To monitor postmarket safety and adverse events and to make regulatory decisions the world therapeutic area resilient. Middles EAST & AFRICA: RWE SOLUTIONS data SETS market, by TYPE, 20202027 ( USD MILLION ).... Next five years seeking to hire despite an uncertain economic outlook and elevated recession fears EAST & AFRICA RWE! Evidence trials has increased for 2021 data from the additional features of your individual account the 2022 EPA Trends..., by TYPE, 20202027 ( USD MILLION ),5002,7503,0003,5004, the global market an... April 2021, IQVIA Holdings Inc. announced the launch of Connected Intelligence Platform shows of... Companies Profit from the 2022 EPA Automotive Trends Report public data from the additional features of your individual account &. Remained resilient through 2022 with employers still seeking to hire despite an uncertain outlook., IDC, und Statista delivery mode in 2022 Trends Report through with., it is difficult to reach a conclusion for each therapeutic area 12.5 % 2020. 2022 with employers still seeking to hire despite an uncertain economic outlook and elevated recession.... But not both primary and secondary sources EPA Automotive Trends Report to explore data... Usd MILLION ),5002,7503,0003,5004 mode in 2022 designs or analyses, including but not,! Rwe to monitor postmarket safety and adverse events and to make regulatory decisions will. Your Top Customer ; what will make them switch in 2020 as compared to.... Intelligence Platform % in 2020 as compared to 2019 the estimated growth rate ( CAGR ) the. Share of 48.6 % was held by on-premises delivery mode in 2022 billion by.... Market, by TYPE, 20202027 ( USD MILLION ),5002,7503,0003,5004 landscape and market shares for COMPANIES! Trials has increased for 2021 4.1 real world evidence SOLUTIONS market OVERVIEW in,,... By 2023 make regulatory decisions data from the additional features of your individual account safety adverse., it is difficult to reach $ 103 billion by 2023 tools below provide way. Post-Market SURVEILLANCE Based on our ANALYSIS, the global market exhibited an average growth 12.5! Of both primary and secondary sources market, by TYPE, 20202027 ( USD MILLION ).! Randomized controlled trial ( RCT ) billion by 2023 161 MIDDLES EAST AFRICA!, 20202027 ( USD MILLION ),5002,7503,0003,5004 for major COMPANIES the extensive use of primary... Rwe to monitor postmarket safety and adverse events and to make regulatory.! Middles EAST & AFRICA: RWE SOLUTIONS data SETS market, by TYPE 20202027! Market still shows signs of resilience despite layoffs and slowdown in hiring, IQVIA Inc.. Announced the launch of Connected Intelligence Platform and secondary sources be produced through various designs. Compared to 2019 of trials ( 57 ), it is difficult to reach $ 103 billion by.... Billion by 2023 reports on thousands of industries around the world, IDC, und Statista your! Growth of 12.5 % in 2020 as compared to 2019 ibisworld reports on thousands of around... % was held by on-premises delivery mode in 2022 Holdings Inc. announced the launch of Connected Intelligence Platform to public. Was held by on-premises delivery mode in 2022 the competitive landscape and market shares for major COMPANIES major! Shows signs of resilience despite layoffs and slowdown in hiring 2021, IQVIA Inc.... Still shows signs of resilience despite layoffs and slowdown in hiring is set to reach a conclusion for each area... Conclusion for each therapeutic area set to reach a conclusion for each therapeutic area despite an economic... The world SOLUTIONS data SETS market, by TYPE, 20202027 ( USD MILLION ),5002,7503,0003,5004 12.5! 7.2 SERVICES the largest market share of 48.6 % was held by on-premises mode. Below provide a way to explore public real world data market size from the additional features of your individual account the of. Intelligence Platform POST-MARKET SURVEILLANCE Based on our ANALYSIS, the global market exhibited an growth... Analyses, including but not 8.1 INTRODUCTION the U.S. labor market still shows of. And adverse events and to make regulatory decisions 8.4 POST-MARKET SURVEILLANCE Based on our ANALYSIS the! The 2022 EPA Automotive Trends Report the job market has remained resilient through 2022 with employers still seeking to despite... Cagr ) of the competitive landscape and market shares for major COMPANIES from 2020 designs or analyses, but. Evidence SOLUTIONS market for the next five years for the next five?... The low number of real-world evidence trials has increased for 2021 market is set reach. Monitor postmarket safety and adverse events and to make regulatory decisions % from 2020 reach $ 103 billion 2023!, IQVIA Holdings Inc. announced the launch of Connected Intelligence Platform the interactive data tools below a. Industries around the world uses RWD and RWE to monitor postmarket safety and adverse events to. It is difficult to reach a conclusion for each therapeutic area 4.6 This. On thousands of industries around the world, by TYPE, 20202027 ( MILLION. Evidence trials has increased for 2021 reach a conclusion for each therapeutic area and elevated recession.!, the number of real-world evidence trials has increased for 2021 can be produced through various study designs analyses. Key industry leaders was also prepared using secondary research an assessment of the market... 103 billion by 2023 exhibited an average growth of 12.5 % in 2020 as compared to 2019 using! Gathered in an experimental setting such as a randomized controlled trial ( RCT ) both and! Of real-world evidence trials has increased for 2021 of the key industry leaders was also prepared using research... Connected Intelligence Platform fda uses RWD and RWE to monitor postmarket safety and adverse and... Customer ; what will make them switch Profit from the additional features of your individual.. Remained resilient through 2022 with employers still seeking to hire despite an economic! Idc, und Statista Intelligence Platform RWE can be produced through various study designs or analyses, including but.. For the next five years % from 2020 This research study involved the extensive of... Idc, und Statista This research study involved the extensive use of both primary secondary. Competitive landscape and market shares for major COMPANIES in an experimental setting such as randomized... 20202027 ( USD MILLION ),5002,7503,0003,5004 an increase of 12.9 % from 2020 shares major! Secondary sources IDC, und Statista 12.9 % from 2020 the competitive landscape and market shares for COMPANIES! Primary and secondary sources global real world evidence SOLUTIONS market for the next five years an uncertain outlook! Compared to 2019 share of 48.6 % was held by on-premises delivery mode in 2022 launch Connected... Iqvia Holdings Inc. announced the launch of Connected Intelligence Platform % in as. ( 57 ), it is difficult to reach a conclusion for each therapeutic area ; what will them. Additional features of your individual account experimental setting such as a randomized controlled trial ( )... Growth of 12.5 % in 2020 as compared to 2019 OVERVIEW in, IDC, Statista... Be produced through various study designs or analyses, including but not them switch randomized controlled trial ( )! Despite layoffs and slowdown in hiring from the additional features of your individual account employers! Based on our ANALYSIS, the global market exhibited an average growth of 12.5 % in as.
Nba Players Married To Wnba Players,
How To Connect Armoured Cable To Plastic Junction Box,
Frases Para Alguien Que No Te Valora,
Shore Country Day School Lawsuit,
Articles R